Viva in Vitro
Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients.
Viva in Vitro has raised €2.5M across 2 funding rounds from 2 investors, most recently a round in Jul 2024. Based in Murcia, Spain; active in Healthtech. Data as of 28 Oct 2026.
Murcia, Spainvivaivd.com ↗
Total raised
€2.5M
€2,500,000
Funding rounds
2
Investors
2
distinct backers
Active since
2023-02
latest 2024-07
Funding by year
EUR raised per yearViva in Vitro — funding by year — interactive chart.
Data table
| Viva in Vitro — funding by year | |
|---|---|
| 2023 | €1.2M |
| 2024 | €1.3M |
Signals
High confidenceRaise-next likelihood16
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-09 | Other | €1.3M | Institute for the Promotion of the Region of Murcia | View deal → |
| 2023-02-24 | Other | €1.2M | Private Investors | View deal → |
Investors
2Institute for the Promotion of the Region of MurciaPrivate Investors
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData